#USA #Chicago #oncology #AACR 2025 #Powered Research

Powered Research Expands into Oncology Services at AACR 2025

At the upcoming AACR Annual Meeting in Chicago on April 28, 2025, Powered Research will present its newly launched oncology preclinical services. With over a decade of experience in the preclinical space, especially in ophthalmology, this initiative marks a significant expansion into oncology.

Industry-Leading Expertise

Powered Research, recognized for its commitment to quality and innovation, has brought on board a team with 130 years of combined expertise in oncology. Senior Vice President David Culp stated, "Our focus on oncology began in 2023, and we are thrilled to share our initial offerings tailored to the specific needs of life sciences research and development companies."

The firm will introduce a range of advanced services, which include:

• - Xenograft and Syngeneic Models for in vivo experiments
• - Radiopharmaceutical Studies to explore targeted therapies
• - Spectral Flow Cytometry for detailed immune profiling
• - Cytokine Analysis from various biological samples
• - Histological Services including IHC and ISH
• - Advanced Microscopy Techniques

A Legacy of Success

Beth Hollister, VP of Operations, emphasized her longstanding commitment to improving cancer treatments. Having founded Piedmont Research Center over 25 years ago, Hollister has successfully led thousands of oncology studies across the globe. She shared her excitement about merging her expertise with Powered Research, declaring, "We are dedicated to quality science and rapid turnaround times to support cancer research's growing demands."

Powered Research has consistently demonstrated the ability to deliver accurate results swiftly while maintaining high standards of data integrity. At AACR 2025, attendees can look forward to detailed presentations about the efficacy of its new spectral cytometry panel, which assesses tumor immune cell populations in mouse models.

Comprehensive Oncology Service Offerings

The oncology service portfolio from Powered Research is extensive and includes:

• - Traditional Human Tumor Models: Xenografts and syngeneic systems to evaluate drug responses.
• - Surgical and Orthotopic Models: Tailored to study tumor dynamics in situ.
• - Radiopharmaceutical Evaluations: Focusing on innovative therapeutic approaches.
• - Flow Cytometry and Deep Immunophenotyping: Utilizing the latest advancements in spectral technology to analyze complex immune responses.
• - Cytokine Profiling: Assessing pivotal immune signaling pathways via serum and tissue samples.
• - In-house Histology Services: Including tissue embedding and cutting to aid in cancer research.
• - Multi-platform Microscopy: Advanced imaging capabilities for thorough analysis.

Leadership and Team Expertise

The Powered Research team comprises seasoned professionals in the field:

• - Beth Hollister: With extensive oncology experience, she leads the operational strategies.
• - Dr. David Culp: Oversees all scientific programs, bringing expertise in oncology and immunology.
• - Kay Meshaw: Manages project phases from design to reporting, ensuring timelines and objectives are met.
• - Dr. Joey Kolb: Specializes in flow cytometry and immunoassay development, with a focus on inflammatory and cancer pathways.

Join Us at AACR 2025

Visit Booth #3154 at AACR 2025 to learn about Powered Research’s capabilities in advancing oncology research. The company is poised to collaborate with drug sponsors and research institutions, aiming to dramatically improve the landscape of cancer therapeutics. For more information about their services and innovations, please reach out or visit Powered Research after the meeting.

Powered Research is excited about this new chapter in their journey and invites all interested parties to connect. Together, we can make strides in cancer research and ultimately, improve patient outcomes.